Granules Pharmaceuticals, Inc. recalls Granules — Metformin Hydrochloride Extended-Release Tablets USP, 750 mg
- Recall date
- July 6, 2020
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Granules Pharmaceuticals, Inc., Granules
Why it was recalled
N-Nitrosodimethylamine (NDMA) — Ingredient Level
What was recalled
Metformin Hydrochloride Extended-Release Tablets USP, 750 mg
Read the official recall notice →
Get recall alerts
Free email alert whenever Granules Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Granules Pharmaceuticals, Inc., Granules